Mhealth and Teach-Back Effectiveness In 30-Day Readmissions Reduction
Condition(s):Readmission; mHealth; Teach-Back CommunicationLast Updated:February 10, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Readmission; mHealth; Teach-Back CommunicationLast Updated:February 10, 2021Unknown status
Condition(s):mHealth; Adherence, PatientLast Updated:July 31, 2020Completed
Condition(s):Adolescent ObesityLast Updated:April 15, 2022Completed
Condition(s):Gambling DisorderLast Updated:March 6, 2024Not yet recruiting
Condition(s):Dialysis Related ComplicationLast Updated:September 22, 2023Active, not recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:August 6, 2020Completed
Condition(s):Type2 Diabetes; ObesityLast Updated:October 22, 2018Completed
Condition(s):Intellectual DisabilityLast Updated:January 10, 2023Completed
Condition(s):Acute Coronary Syndrome; Percutaneous Coronary Intervention; BleedingLast Updated:November 13, 2018Unknown status
Condition(s):Stone, KidneyLast Updated:March 27, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.